OCT initiates clinical trial in Breast Cancer

25 October 2007

Along with a high- profile Scientific Organization in Italy OCT initiates clinical trial in Breast Cancer, 8 sites, 60 patients.

OCT Vision

“OCT vision is to be recognized by pharmaceutical and biotech companies as a leading provider of clinical trials in Russia, Ukraine, Bulgaria, Belarus, Latvia, Lithuania, Estonia, Poland and Czech Republic. OCT is able to support any requirements that clients may have in the region, ranging from one-off advice to full-study implementation and execution. We are determined and decisive in expanding our activity at this rapidly growing market”— Dmitry Sharov, General Manager of OCT.